Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
4.050
+0.190 (4.92%)
At close: Dec 20, 2024, 4:00 PM
4.020
-0.030 (-0.74%)
After-hours: Dec 20, 2024, 6:47 PM EST
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $151.57 million as of December 20, 2024.
Market Cap
151.57M
Enterprise Value
-76.95M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $151.57M, a decrease of -73.07%. That is a compound annual growth rate of -78.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 151.57M | -73.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 155.02M |
| Adaptimmune Therapeutics | 154.78M |
| The Joint | 153.88M |
| Telomir Pharmaceuticals | 153.38M |
| Biomea Fusion | 153.29M |
| Zura Bio | 148.87M |
| Aligos Therapeutics | 147.87M |
| Nevro | 142.02M |